查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587364

综合代谢面板测试市场：按疾病、测试类型、最终用户划分 - 全球预测 2025-2030

Comprehensive Metabolic Panel Testing Market by Disease (Diabetes, Kidney Disease, Liver Disease), Test Type (Electrolytes, Glucose, Kidney Tests), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

综合代谢面板测试市场2023年估值为92.8亿美元，预计到2024年将达到102.6亿美元，复合年增长率为10.65%，预计到2030年将达到188.6亿美元。

综合代谢组 (CMP) 测试市场包括各种诊断性血液测试，可测量血糖水平、电解质平衡、肾功能、肝臟状态，并提供有关患者整体代谢健康状况的重要资料。由于文明病和慢性病的增加，CMP检测被广泛应用于常规健康检查和疾病进展监测。医疗保健提供者、实验室和医院是主要的最终用户，而患者对预防性护理和就地检验解决方案的偏好的增加正在推动需求。市场洞察揭示了导致需求激增的关键成长要素，包括自动化测试技术的进步、向个人化医疗的转变以及新兴国家医疗保健基础设施的扩张。潜在的机会存在于提高诊断准确性、整合人工智慧以更好地解释资料以及开发家用可携式测试设备。然而，监管障碍、与先进诊断工具相关的高成本以及某些地区缺乏意识等挑战可能会阻碍市场成长。价格敏感度和报销问题使市场动态更加复杂。随着该行业寻求克服这些障碍，创新领域已经成熟，包括开发下一代生物标记物组、改进机器学习演算法以实现更好的诊断预测以及可访问性和患者参与，其中包括远端医疗平台和CMP 测试的整合以增加。随着公私伙伴关係关係促进市场扩张，降低成本和提高意识的努力可以产生正面成果。 CMP 测试市场的基本性质很强大，但仍在不断发展，主要是由技术整合以及对健康和福祉意识的重视所推动的。

主要市场统计
基准年[2023] 92.8亿美元
预测年份 [2024] 102.6亿美元
预测年份 [2030] 188.6亿美元
复合年增长率（%） 10.65%

市场动态：快速发展的综合代谢面板测试市场的关键市场洞察

供需的动态交互作用正在改变综合代谢组测试市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病盛行率增加
    • 人群早期诊断和治疗的潜在需求
    • 老年人口不断增加，切片检查过程不断增加
  • 市场限制因素
    • 测试结果错误的可能性
  • 市场机会
    • 介绍旨在提高效率和减少错误的创新解决方案的兴起
    • 实验室自动化系统与生物资讯学和资料管理解决方案的持续集成
  • 市场挑战
    • 由于监管体系的变化导致製造商之间的模糊性

波特的五力：驾驭综合代谢面板测试市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更具弹性的市场地位。

PESTLE分析：了解综合代谢面板测试市场的外部影响

外部宏观环境因素在塑造综合代谢组测试市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解综合代谢组测试市场的竞争状况

综合代谢面板测试市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵综合代谢组测试市场供应商绩效评估

FPNV定位矩阵是评估综合代谢组测试市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製综合代谢面板测试市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对综合代谢组测试市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病发生率增加
      • 人群早期诊断和治疗的需要
      • 老年人口不断增加，切片检查数量不断增加
    • 抑制因素
      • 测试给出错误结果的机率
    • 机会
      • 介绍可提高效率并减少错误的创新解决方案
      • 生物资讯学和资料管理解决方案与实验室自动化系统的持续集成
    • 任务
      • 监管体系的变化在製造商之间造成了模糊性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章综合代谢面板测试市场：依疾病分类

  • 糖尿病
  • 肾臟疾病
  • 肝臟疾病

第七章按测试类型分類的综合代谢组测试市场

  • 电解质
  • 葡萄糖
  • 肾臟测试
  • 肝功能检查
  • 蛋白质

第八章综合代谢组测试市场：依最终用户分类

  • 实验室
  • 概念验证

第九章北美和南美综合代谢组测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区综合代谢组测试市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲综合代谢组检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abaxis by Zoetis Inc.
  • Abbott Laboratories
  • ARUP Laboratories
  • Baptist Health Medical Group
  • CENTOGENE NV
  • Cleveland HeartLab, Inc.
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories, Inc.
  • Private MD Labs
  • Quest Diagnostics Incorporated
  • Scion Lab Services, LLC
  • Siemens Healthcare GmbH
  • SYNLAB International GmbH
  • Testing.com by OneCare Media
  • Walk-In Lab, LLC
Product Code: MRR-ED54C46E80B0

The Comprehensive Metabolic Panel Testing Market was valued at USD 9.28 billion in 2023, expected to reach USD 10.26 billion in 2024, and is projected to grow at a CAGR of 10.65%, to USD 18.86 billion by 2030.

The Comprehensive Metabolic Panel (CMP) testing market encompasses a wide range of diagnostic blood tests that measure glucose levels, electrolyte balance, kidney function, and liver status to provide essential data on a patient's overall metabolic health. Necessitated by the growing incidence of lifestyle-related disorders and chronic diseases, CMP testing finds extensive application in both routine health examinations and the monitoring of disease progression. Healthcare providers, laboratories, and hospitals serve as primary end-users, while the increasing patient preference for preventive healthcare and point-of-care testing solutions drives demand. Market insights reveal key growth factors, such as advancements in automated testing technologies, the shift towards personalized medicine, and expanding healthcare infrastructure in emerging economies, which contribute significantly to the demand surge. Potential opportunities exist in enhancing diagnostic accuracy, integrating artificial intelligence for better data interpretation, and developing portable testing equipment for home use. However, challenges such as regulatory hurdles, high costs associated with advanced diagnostic tools, and a lack of awareness in certain regions could hinder market growth. Price sensitivity and reimbursement issues further complicate market dynamics. As the industry aims to cross these hurdles, areas ripe for innovation include the development of next-generation biomarker panels, improvement in machine learning algorithms for better diagnostic predictions, and the integration of telehealth platforms with CMP testing to enhance accessibility and patient engagement. Efforts towards reducing costs and promoting awareness could yield favorable outcomes, with partnerships between private and public sectors fostering market expansion. The underlying nature of the CMP testing market is robust yet evolving, primarily driven by technological integration and a strong emphasis on health and well-being awareness, presenting a compelling case for stakeholders to invest in future-forward diagnostics.

KEY MARKET STATISTICS
Base Year [2023] USD 9.28 billion
Estimated Year [2024] USD 10.26 billion
Forecast Year [2030] USD 18.86 billion
CAGR (%) 10.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Comprehensive Metabolic Panel Testing Market

The Comprehensive Metabolic Panel Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of chronic diseases
    • Potential need for early diagnosis and treatment among the population
    • Rising elderly population coupled with increase in biopsy processes
  • Market Restraints
    • Probability of false results on testing
  • Market Opportunities
    • Emerging introduction of innovative solutions to improve efficiency and reduce errors
    • Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
  • Market Challenges
    • Changing regulatory system creating ambiguity among manufacturers

Porter's Five Forces: A Strategic Tool for Navigating the Comprehensive Metabolic Panel Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Comprehensive Metabolic Panel Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Comprehensive Metabolic Panel Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Comprehensive Metabolic Panel Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Comprehensive Metabolic Panel Testing Market

A detailed market share analysis in the Comprehensive Metabolic Panel Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Comprehensive Metabolic Panel Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Comprehensive Metabolic Panel Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Comprehensive Metabolic Panel Testing Market

A strategic analysis of the Comprehensive Metabolic Panel Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Comprehensive Metabolic Panel Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis by Zoetis Inc., Abbott Laboratories, ARUP Laboratories, Baptist Health Medical Group, CENTOGENE N.V., Cleveland HeartLab, Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., Private MD Labs, Quest Diagnostics Incorporated, Scion Lab Services, LLC, Siemens Healthcare GmbH, SYNLAB International GmbH, Testing.com by OneCare Media, and Walk-In Lab, LLC.

Market Segmentation & Coverage

This research report categorizes the Comprehensive Metabolic Panel Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease, market is studied across Diabetes, Kidney Disease, and Liver Disease.
  • Based on Test Type, market is studied across Electrolytes, Glucose, Kidney Tests, Liver Functional Tests, and Proteins.
  • Based on End-User, market is studied across Laboratory and PoC.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic diseases
      • 5.1.1.2. Potential need for early diagnosis and treatment among the population
      • 5.1.1.3. Rising elderly population coupled with increase in biopsy processes
    • 5.1.2. Restraints
      • 5.1.2.1. Probability of false results on testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging introduction of innovative solutions to improve efficiency and reduce errors
      • 5.1.3.2. Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Changing regulatory system creating ambiguity among manufacturers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Comprehensive Metabolic Panel Testing Market, by Disease

  • 6.1. Introduction
  • 6.2. Diabetes
  • 6.3. Kidney Disease
  • 6.4. Liver Disease

7. Comprehensive Metabolic Panel Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Electrolytes
  • 7.3. Glucose
  • 7.4. Kidney Tests
  • 7.5. Liver Functional Tests
  • 7.6. Proteins

8. Comprehensive Metabolic Panel Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Laboratory
  • 8.3. PoC

9. Americas Comprehensive Metabolic Panel Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Comprehensive Metabolic Panel Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Comprehensive Metabolic Panel Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abaxis by Zoetis Inc.
  • 2. Abbott Laboratories
  • 3. ARUP Laboratories
  • 4. Baptist Health Medical Group
  • 5. CENTOGENE N.V.
  • 6. Cleveland HeartLab, Inc.
  • 7. Laboratory Corporation of America Holdings
  • 8. NeoGenomics Laboratories, Inc.
  • 9. Private MD Labs
  • 10. Quest Diagnostics Incorporated
  • 11. Scion Lab Services, LLC
  • 12. Siemens Healthcare GmbH
  • 13. SYNLAB International GmbH
  • 14. Testing.com by OneCare Media
  • 15. Walk-In Lab, LLC

LIST OF FIGURES

  • FIGURE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMPREHENSIVE METABOLIC PANEL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER FUNCTIONAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY POC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2023